Table 2. Seroprevalence of HBcAb in male and female subjects in different age groups.

Age group	Male (%)	Female (%)	Total (%)
6–29 years	13	13.8	13.5
30–45 years	26.2	25.7	26.3
46–65 years	54	38	45.6